Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JANX008 |
Trade Name | |
Synonyms | JANX-008|JANX 008 |
Drug Descriptions |
JANX008 is a tumor-activated T cell engager (TRACTr) targeting EGFR and CD3, which potentially inhibits tumor growth (Cancer Immunol Res 2022;10(12 Suppl):Abstract nr B04). |
DrugClasses | CD3 Antibody 99 EGFR Antibody 60 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JANX008 | JANX008 | 0 | 1 |